Erratum: Targeted gene silencing using RGD-labeled chitosan nanoparticles (Clinical Cancer Research (2010) 16 (3910-3922) DOI: 10.1158/1078-0432.CCR-10-0005)

Hee Dong Han, Lingegowda S. Mangala, Jeong Won Lee, Mian M.K. Shahzad, Hye Sun Kim, Deyu Shen, Eun Ji Nam, Edna M. Mora, Rebecca L. Stone, Chunhua Lu, Sun Joo Lee, Ju Won Roh, Alpa M. Nick, Gabriel Lopez-Berestein, Anil K. Sood

Research output: Contribution to journalComment/debatepeer-review

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): in Supplementary Fig. S6B, one of the representative CD31 images was duplicated between the “FAK/CH-NPþDocetaxel” and “FAK/RGD-CH-NPþDocetaxel” groups. MD Anderson’s Office of Research Oversight and Integrity evaluated this error and data from the authors; while the Office concluded it had no concerns regarding this publication, it recommended correction of the scientific record. The authors apologize for this error.

Original languageEnglish (US)
Pages (from-to)4453
Number of pages1
JournalClinical Cancer Research
Volume27
Issue number15
DOIs
StatePublished - Aug 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: Targeted gene silencing using RGD-labeled chitosan nanoparticles (Clinical Cancer Research (2010) 16 (3910-3922) DOI: 10.1158/1078-0432.CCR-10-0005)'. Together they form a unique fingerprint.

Cite this